Peroxisome proliferating activating receptor gamma-independent attenuation of interleukin 6 and interleukin 8 secretion from primary endometrial stromal cells by thiazolidinediones

Brett McKinnon, Bersinger NA, Nick A. Bersinger, Michael D. Mueller
Fertility and sterility · 2011 · vol. 97(3) , pp. 657–664 · doi:10.1016/j.fertnstert.2011.12.001 · PMID:22192353 · W2060445679
Lab / animal OA: bronze CC0 ⤵ 10 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

Thiazolidinediones were investigated for their ability to reduce interleukin 6 and interleukin 8 secretion from endometrial stromal cells independently of peroxisome proliferating activating receptor gamma.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To assess the effect of thiazolidinediones on the regulation of inflammatory cytokines related to endometriosis in endometrial tissue and determine whether these effects occur via activation of the peroxisome proliferating activating receptor gamma (PPAR)-γ. DESIGN: In vitro study using eutopic endometrial tissue. SETTING: University hospital. PATIENT(S): Premenopausal women undergoing laparoscopy for infertility or abdominal pain. INTERVENTION(S): Isolation of endometrial stromal cells and the culture of these cells in the presence of thiazolidinediones, ciglitazone and pioglitazone, both with and without a pretreatment of the specific, irreversible PPAR-γ antagonist GW9662. MAIN OUTCOME MEASURE(S): Quantitation of interleukin (IL)-6 and IL-8 released into the cell culture medium by ELISA. Real-time polymerase chain reaction to quantitate PPAR-γ gene expression in the primary cell preparations and the expression of IL-6 and IL-8 after thiazolidinedione treatment. RESULT(S): Treatment of stromal cells with thiazolidinediones attenuated IL-6 and IL-8 release in a dose-dependent manner. This effect was not inhibited by GW9662 pretreatment. Ciglitazone induced IL-6 messenger RNA expression, an effect that was suppressed by GW9662 pretreatment. CONCLUSION(S): Thiazolidinediones decrease the proinflammatory cytokines IL-6 and IL-8 in endometrial stromal cells via a PPAR-γ-independent mechanism. A better understanding of the anti-inflammatory action of this class of drugs may improve their safety and efficacy for endometriosis treatment.

My notes (saved in your browser only)

MeSH descriptors

Anti-Inflammatory Agents Endometrium Inflammation Mediators Interleukin-6 Interleukin-8 PPAR gamma Stromal Cells Thiazolidinediones Anilides Anilides Anilides Anti-Inflammatory Agents Anti-Inflammatory Agents Cells, Cultured Cells, Cultured Dose-Response Relationship, Drug Dose-Response Relationship, Drug Down-Regulation Down-Regulation Endometrium

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (49)

Cited by (10)

Source provenance

europepmc
last seen: 2026-10-17T06:09:56.316927+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:09:44.076416+00:00
License: CC0 · commercial use OK